
A very profitable quarter
CME Group kicked off 2026 with a flex: record revenue of $1.9 billion, up 14% from a year ago, plus record adjusted operating income, adjusted net income, and adjusted EPS. In plain English, more people kept showing up to trade, hedge, and generally make CME’s pipes worth paying for.
Why you should care
This is the kind of update investors like because CME doesn’t need a blockbuster product launch or a flashy consumer trend to win. It makes money when markets are active, and active markets tend to mean more volume, more fees, and more recurring cash flow. That’s the exchange version of selling shovels in a gold rush.
The takeaway
The company reported net income and diluted EPS were both up 20%, which tells you this wasn’t just a revenue story — it was a real bottom-line move too. If you own CME, you’re basically betting on continued market churn, interest-rate drama, and traders doing what traders do best: move fast and pay up.
Big picture
CME’s quarter says the trading backdrop is still alive and kicking. If volatility sticks around, the company’s boring-but-beautiful business model keeps looking pretty attractive.
